Derangement of transcription factor profiles during in vitro differentiation of HL60 and NB4 cells

Leukemia Research

Volumn 31, Issue 6, 2007, Pages 827-837

  Pass, Malene Bjerregaard ^a   Borregaard, Niels ^a   Cowland, Jack Bernard ^a  

^a Rigshospitalet   (Denmark)

Author keywords

AML; C EBP; Granule proteins; Granulopoiesis; HL60; NB4; PU.1; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GRANULOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NEUTROPHIL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMYELOCYTE;

CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GRANULOCYTE PRECURSOR CELLS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOPOIESIS; MODELS, BIOLOGICAL; NEUTROPHILS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 34249820775     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.07.019     Document Type: Article

References (47)

1. Yamagata T., Maki K., and Mitani K. Runx1/AML1 in normal and abnormal hematopoiesis. Int J Hematol 82 (2005) 1-8
2. Pabst T., Mueller B.U., Zhang P., Radomska H.S., Narravula S., Schnittger S., et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27 (2001) 263-270
3. Pabst T., Mueller B.U., Harakawa N., Schoch C., Haferlach T., Behre G., et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 7 (2001) 444-451
4. Westendorf J.J., Yamamoto C.M., Lenny N., Downing J.R., Selsted M.E., and Hiebert S.W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol 18 (1998) 322-333
5. Mueller B.U., Pabst T., Osato M., Asou N., Johansen L.M., Minden M.D., et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 100 (2002) 998-1007
6. Lekstrom H.J., Dorman S.E., Kopar P., Holland S.M., and Gallin J.I. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med 189 (1999) 1847-1852
7. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
8. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., and Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93 (1996) 3444-3449
9. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65 (1991) 677-689
10. Zhang D.E., Zhang P., Wang N.D., Hetherington C.J., Darlington G.J., and Tenen D.G. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94 (1997) 569-574
11. Zhang P., Iwasaki-Arai J., Iwasaki H., Fenyus M.L., Dayaram T., Owens B.M., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21 (2004) 853-863
12. Yamanaka R., Barlow C., Lekstrom-Himes J., Castilla L.H., Liu P.P., Eckhaus M., et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94 (1997) 13187-13192
13. Lekstrom-Himes J., and Xanthopoulos K.G. CCAAT/enhancer binding protein epsilon is critical for effective neutrophil-mediated response to inflammatory challenge. Blood 93 (1999) 3096-3105
14. Verbeek W., Lekstrom-Himes J., Park D.J., Dang P.M., Vuong P.T., Kawano S., et al. Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood 94 (1999) 3141-3150
15. Scott E.W., Simon M.C., Anastasi J., and Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
16. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15 (1996) 5647-5658
17. Anderson K.L., Smith K.A., Pio F., Torbett B.E., and Maki R.A. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 92 (1998) 1576-1585
18. Kim H.G., de Guzman C.G., Swindle C.S., Cotta C.V., Gartland L., Scott E.W., et al. The ETS family transcription factor PU.1 is necessary for the maintenance of fetal liver hematopoietic stem cells. Blood 104 (2004) 3894-3900
19. Iwasaki H., Somoza C., Shigematsu H., Duprez E.A., Iwasaki-Arai J., Mizuno S., et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106 (2005) 1590-1600
20. DeKoter R.P., and Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288 (2000) 1439-1441
21. Koschmieder S., Rosenbauer F., Steidl U., Owens B.M., and Tenen D.G. Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia. Int J Hematol 81 (2005) 368-377
22. Dahl R., Walsh J.C., Lancki D., Laslo P., Iyer S.R., Singh H., et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 4 (2003) 1029-1036
23. Collins S.J., Ruscetti F.W., Gallagher R.E., and Gallo R.C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci 75 (1978) 2458-2462
24. Breitman T.R., and He R.Y. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Cancer Res 50 (1990) 6268-6273
25. Le Cabec V., Cowland J.B., Calafat J., and Borregaard N. Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc Natl Acad Sci USA 93 (1996) 6454-6457
26. Johnston J.J., Rintels P., Chung J., Sather J., Benz Jr. E.J., and Berliner N. Lactoferrin gene promoter: structural integrity and nonexpression in HL60 cells. Blood 79 (1992) 2998-3006
27. Le Cabec V., Calafat J., and Borregaard N. Sorting of the specific granule protein, NGAL, during granulocytic maturation of HL-60 cells. Blood 89 (1997) 2113-2121
28. Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., and Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77 (1991) 1080-1086
29. Khanna-Gupta A., Kolibaba K., Zibello T.A., and Berliner N. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 84 (1994) 294-302
30. Gregoire C., Welch H., Astarie-Dequeker C., and Maridonneau-Parini I. Expression of azurophil and specific granule proteins during differentiation of NB4 cells in neutrophils. J Cell Physiol 175 (1998) 203-210
31. Bjerregaard M.D., Jurlander J., Klausen P., Borregaard N., and Cowland J.B. The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow. Blood 101 (2003) 4322-4332
32. Lund J.F., and Terstappen L.W. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 54 (1993) 47-55
33. Cowland J.B., and Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 66 (1999) 989-995
34. Chih D.Y., Chumakov A.M., Park D.J., Silla A.G., and Koeffler H.P. Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). Blood 90 (1997) 2987-2994
35. Yamanaka R., Kim G.-D., Radomska H.S., Lekstrom-Himes J., Smith L.T., Antonson P., et al. CCAAT/enhancer binding protein ε is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci 94 (1997) 6462-6467
36. Park D.J., Chumakov A.M., Vuong P.T., Chih D.Y., Gombart A.F., Miller W.H.J., et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 103 (1999) 1399-1408
37. Hromas R., Collins S.J., Hickstein D., Raskind W., Deaven L.L., O'Hara P., et al. A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem 266 (1991) 14183-14187
38. Scott L.M., Civin C.I., Rorth P., and Friedman A.D. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80 (1992) 1725-1735
39. Radomska H.S., Huettner C.S., Zhang P., Cheng T., Scadden D.T., and Tenen D.G. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 18 (1998) 4301-4314
40. Gery S., Park D.J., Vuong P.T., Chih D.Y., Lemp N., and Koeffler H.P. Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes. Blood 104 (2004) 3911-3917
41. Khanna-Gupta A., Zibello T., Sun H., Gaines P., and Berliner N. Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBP alpha and C/EBP epsilon) and CDP/cut in myeloid maturation-induced lactoferrin gene expression. Blood 101 (2003) 3460-3468
42. Gombart A.F., Kwok S.H., Anderson K.L., Yamaguchi Y., Torbett B.E., and Koeffler H.P. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. Blood 101 (2003) 3265-3273
43. Verbeek W., Gombart A.F., Chumakov A.M., Muller C., Friedman A.D., and Koeffler H.P. C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood 93 (1999) 3327-3337
44. Khanna-Gupta A., Zibello T., Kolla S., Neufeld E.J., and Berliner N. CCAAT displacement protein (CDP/cut) recognizes a silencer element within the lactoferrin gene promoter. Blood 90 (1997) 2784-2795
45. Lievens P.M., Donady J.J., Tufarelli C., and Neufeld E.J. Repressor activity of CCAAT displacement protein in HL-60 myeloid leukemia cells. J Biol Chem 270 (1995) 12745-12750
46. Khanna-Gupta A., Zibello T., Simkevich C., Rosmarin A.G., and Berliner N. Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation. Blood 95 (2000) 3734-3741
47. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111 (2002) 621-633